Home › Funds › Point72 Asset Management › AVIR
Point72 Asset Management position in AVIR
ATEA PHARMACEUTICALS INC · Health Care
Latest position (Q1 2026)119.55K sh
Reported value held$643.20K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 332.20K | $11.65M | New |
| Q1 2023 | 36.68K | $122.88K | New |
| Q2 2023 | 9 | $34 | Reduce |
| Q4 2025 | 63.91K | $228.14K | New |
| Q1 2026 | 119.55K | $643.20K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AVIR
- Fidelity Management & Research (FMR) 12.00M sh · $55.82M · Q2 2026
- BlackRock Inc 8.72M sh · $40.55M · Q2 2026
- Vanguard Group 4.23M sh · $15.09M · Q4 2025
- Geode Capital Management 1.96M sh · $9.11M · Q2 2026
- Two Sigma Investments 1.51M sh · $7.01M · Q2 2026
- Renaissance Technologies 1.13M sh · $5.26M · Q2 2026
- JPMorgan Chase & Co 945.92K sh · $4.36M · Q2 2026
- Northern Trust Corp 755.24K sh · $3.51M · Q2 2026
- Morgan Stanley 719.51K sh · $3.35M · Q2 2026
- Charles Schwab Investment Management 610.61K sh · $2.84M · Q2 2026
- Goldman Sachs Group 530.86K sh · $2.47M · Q2 2026
- D. E. Shaw & Co 345.19K sh · $1.61M · Q2 2026